With over 23485.0 Liminal BioSciences Inc. (LMNL) shares trading Tuesday and a closing price of $12.15 on the day, the dollar volume was approximately $0.29 million. The shares have shown a negative weekly performance of -3.42% and its price on 07/21/20 lost nearly -2.02%. Currently, there are 23.42M common shares owned by the public and among those 3.38M shares have been available to trade.
The top 3 mutual fund holders in Liminal BioSciences Inc. are New Zealand Superannuation Fund, Vifag 2002, SICAV, and FDC SICAV – Actions Monde Small C. New Zealand Superannuation Fund owns 284.0 shares of the company’s stock, all valued at over $3067.0. The company bought an additional 222.0 shares recently to bring their total holdings to about 0.00% of the shares outstanding. Vifag 2002, SICAV bought 31.0 shares to see its total holdings expand to 164.0 shares valued at over $1771.0 and representing 0.00% of the shares outstanding. FDC SICAV – Actions Monde Small C sold 82.0 shares to bring its total holdings to over 0.0 shares at a value of $0.0. FDC SICAV – Actions Monde Small C now owns shares totaling to 0.00% of the shares outstanding.
Shares of Liminal BioSciences Inc. (NASDAQ: LMNL) opened at $12.34, down -$0.06 from a prior closing price of $12.40. However, the script later closed the day at $12.15, down -2.02%. The company’s stock has a 5-day price change of -3.42% and 55.47% over the past three months. LMNL shares are trading 44.99% year to date (YTD), with the 12-month market performance down to -68.85% lower. It has a 12-month low price of $5.25 and touched a high of $31.45 over the same period. Currently, 23485.0 shares have been traded, compared to an average intraday trading volume of 67.98K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.48%, 14.08%, and 36.00% respectively.
Institutional ownership of Liminal BioSciences Inc. (NASDAQ: LMNL) shares accounts for 14.23% of the company’s 23.42M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $284.56M. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.08% over the week and 19.87% over the month.
Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 2 of the 2 advise that investors “hold,” and 0 rated it as a “Sell.”